Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1997 May 15;99(10):2502–2508. doi: 10.1172/JCI119434

A decline in myometrial nitric oxide synthase expression is associated with labor and delivery.

R K Bansal 1, P C Goldsmith 1, Y He 1, C J Zaloudek 1, J L Ecker 1, R K Riemer 1
PMCID: PMC508091  PMID: 9153294

Abstract

The mechanisms that maintain relative uterine quiescence during pregnancy remain largely unknown. A possible role for nitric oxide has recently emerged, however, the expression of nitric oxide synthase within human myometrium at midgestation, a time when the uterus is normally quiescent, has not been investigated. The purpose of this study was to identify cell types in human myometrium that contain inducible nitric oxide synthase (iNOS), and to examine changes in its expression during pregnancy and labor. We found that iNOS is expressed in smooth muscle cells of pregnant myometrium. Expression of iNOS was highest in myometrium of preterm not-in-labor patients. At term, iNOS expression fell by 75%, and was barely detectable in preterm in-labor or term in-labor specimens. There was no staining in the myocytes of nonpregnant myometrium. Western blotting also revealed a similar pattern of changes in iNOS expression. In summary, iNOS expression in the myocytes of human myometrium is increased greatly during pregnancy, and declines towards term or with labor. Significantly, preterm inlabor patients also had a large decline in iNOS expression. These data suggest that changes in myometrial iNOS expression may participate in the regulation of uterine activity during human pregnancy.

Full Text

The Full Text of this article is available as a PDF (285.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arceci R. J., Shanahan F., Stanley E. R., Pollard J. W. Temporal expression and location of colony-stimulating factor 1 (CSF-1) and its receptor in the female reproductive tract are consistent with CSF-1-regulated placental development. Proc Natl Acad Sci U S A. 1989 Nov;86(22):8818–8822. doi: 10.1073/pnas.86.22.8818. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bredt D. S., Hwang P. M., Glatt C. E., Lowenstein C., Reed R. R., Snyder S. H. Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase. Nature. 1991 Jun 27;351(6329):714–718. doi: 10.1038/351714a0. [DOI] [PubMed] [Google Scholar]
  3. Bry K., Hallman M. Transforming growth factor-beta 2 prevents preterm delivery induced by interleukin-1 alpha and tumor necrosis factor-alpha in the rabbit. Am J Obstet Gynecol. 1993 Apr;168(4):1318–1322. doi: 10.1016/0002-9378(93)90388-y. [DOI] [PubMed] [Google Scholar]
  4. Buhimschi I., Yallampalli C., Dong Y. L., Garfield R. E. Involvement of a nitric oxide-cyclic guanosine monophosphate pathway in control of human uterine contractility during pregnancy. Am J Obstet Gynecol. 1995 May;172(5):1577–1584. doi: 10.1016/0002-9378(95)90500-6. [DOI] [PubMed] [Google Scholar]
  5. Das S. K., Flanders K. C., Andrews G. K., Dey S. K. Expression of transforming growth factor-beta isoforms (beta 2 and beta 3) in the mouse uterus: analysis of the periimplantation period and effects of ovarian steroids. Endocrinology. 1992 Jun;130(6):3459–3466. doi: 10.1210/endo.130.6.1375903. [DOI] [PubMed] [Google Scholar]
  6. Denis M. Human monocytes/macrophages: NO or no NO? J Leukoc Biol. 1994 May;55(5):682–684. doi: 10.1002/jlb.55.5.682. [DOI] [PubMed] [Google Scholar]
  7. Ding A. H., Nathan C. F., Stuehr D. J. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J Immunol. 1988 Oct 1;141(7):2407–2412. [PubMed] [Google Scholar]
  8. Förstermann U., Pollock J. S., Schmidt H. H., Heller M., Murad F. Calmodulin-dependent endothelium-derived relaxing factor/nitric oxide synthase activity is present in the particulate and cytosolic fractions of bovine aortic endothelial cells. Proc Natl Acad Sci U S A. 1991 Mar 1;88(5):1788–1792. doi: 10.1073/pnas.88.5.1788. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. How H., Huang Z. H., Zuo J., Lei Z. M., Spinnato J. A., 2nd, Rao C. V. Myometrial estradiol and progesterone receptor changes in preterm and term pregnancies. Obstet Gynecol. 1995 Dec;86(6):936–940. doi: 10.1016/0029-7844(95)00306-C. [DOI] [PubMed] [Google Scholar]
  10. Huang J., Roby K. F., Pace J. L., Russell S. W., Hunt J. S. Cellular localization and hormonal regulation of inducible nitric oxide synthase in cycling mouse uterus. J Leukoc Biol. 1995 Jan;57(1):27–35. doi: 10.1002/jlb.57.1.27. [DOI] [PubMed] [Google Scholar]
  11. Izumi H., Yallampalli C., Garfield R. E. Gestational changes in L-arginine-induced relaxation of pregnant rat and human myometrial smooth muscle. Am J Obstet Gynecol. 1993 Nov;169(5):1327–1337. doi: 10.1016/0002-9378(93)90301-x. [DOI] [PubMed] [Google Scholar]
  12. KUMAR D., ZOURLAS P. A., BARNES A. C. IN VIVO EFFECT OF AMYL NITRITE ON HUMAN PREGNANT UTERINE CONTRACTILITY; AN OBJECTIVE EVALUATION. Am J Obstet Gynecol. 1965 Apr 15;91:1066–1068. doi: 10.1016/0002-9378(65)90703-9. [DOI] [PubMed] [Google Scholar]
  13. Kimura T., Takemura M., Nomura S., Nobunaga T., Kubota Y., Inoue T., Hashimoto K., Kumazawa I., Ito Y., Ohashi K. Expression of oxytocin receptor in human pregnant myometrium. Endocrinology. 1996 Feb;137(2):780–785. doi: 10.1210/endo.137.2.8593830. [DOI] [PubMed] [Google Scholar]
  14. Lamas S., Marsden P. A., Li G. K., Tempst P., Michel T. Endothelial nitric oxide synthase: molecular cloning and characterization of a distinct constitutive enzyme isoform. Proc Natl Acad Sci U S A. 1992 Jul 15;89(14):6348–6352. doi: 10.1073/pnas.89.14.6348. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Lees C., Campbell S., Jauniaux E., Brown R., Ramsay B., Gibb D., Moncada S., Martin J. F. Arrest of preterm labour and prolongation of gestation with glyceryl trinitrate, a nitric oxide donor. Lancet. 1994 May 28;343(8909):1325–1326. doi: 10.1016/s0140-6736(94)92468-6. [DOI] [PubMed] [Google Scholar]
  16. Lowenstein C. J., Dinerman J. L., Snyder S. H. Nitric oxide: a physiologic messenger. Ann Intern Med. 1994 Feb 1;120(3):227–237. doi: 10.7326/0003-4819-120-3-199402010-00009. [DOI] [PubMed] [Google Scholar]
  17. Malinski T., Taha Z., Grunfeld S., Patton S., Kapturczak M., Tomboulian P. Diffusion of nitric oxide in the aorta wall monitored in situ by porphyrinic microsensors. Biochem Biophys Res Commun. 1993 Jun 30;193(3):1076–1082. doi: 10.1006/bbrc.1993.1735. [DOI] [PubMed] [Google Scholar]
  18. Moncada S., Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med. 1993 Dec 30;329(27):2002–2012. doi: 10.1056/NEJM199312303292706. [DOI] [PubMed] [Google Scholar]
  19. Nathan C., Xie Q. W. Regulation of biosynthesis of nitric oxide. J Biol Chem. 1994 May 13;269(19):13725–13728. [PubMed] [Google Scholar]
  20. Natuzzi E. S., Ursell P. C., Harrison M., Buscher C., Riemer R. K. Nitric oxide synthase activity in the pregnant uterus decreases at parturition. Biochem Biophys Res Commun. 1993 Jul 15;194(1):1–8. doi: 10.1006/bbrc.1993.1776. [DOI] [PubMed] [Google Scholar]
  21. Peng A. T., Gorman R. S., Shulman S. M., DeMarchis E., Nyunt K., Blancato L. S. Intravenous nitroglycerin for uterine relaxation in the postpartum patient with retained placenta. Anesthesiology. 1989 Jul;71(1):172–173. doi: 10.1097/00000542-198907000-00039. [DOI] [PubMed] [Google Scholar]
  22. Ramsay B., Sooranna S. R., Johnson M. R. Nitric oxide synthase activities in human myometrium and villous trophoblast throughout pregnancy. Obstet Gynecol. 1996 Feb;87(2):249–253. doi: 10.1016/0029-7844(95)00391-6. [DOI] [PubMed] [Google Scholar]
  23. Rowe A., Farrell A., Kazmi S. H., Bunker C. B. Expression of inducible nitric oxide synthase in dermal microvasculature in psoriasis. Lancet. 1994 Nov 12;344(8933):1371–1371. doi: 10.1016/s0140-6736(94)90734-x. [DOI] [PubMed] [Google Scholar]
  24. Sherman P. A., Laubach V. E., Reep B. R., Wood E. R. Purification and cDNA sequence of an inducible nitric oxide synthase from a human tumor cell line. Biochemistry. 1993 Nov 2;32(43):11600–11605. doi: 10.1021/bi00094a017. [DOI] [PubMed] [Google Scholar]
  25. Sladek S. M., Regenstein A. C., Lykins D., Roberts J. M. Nitric oxide synthase activity in pregnant rabbit uterus decreases on the last day of pregnancy. Am J Obstet Gynecol. 1993 Nov;169(5):1285–1291. doi: 10.1016/0002-9378(93)90295-t. [DOI] [PubMed] [Google Scholar]
  26. Telfer J. F., Lyall F., Norman J. E., Cameron I. T. Identification of nitric oxide synthase in human uterus. Hum Reprod. 1995 Jan;10(1):19–23. doi: 10.1093/humrep/10.1.19. [DOI] [PubMed] [Google Scholar]
  27. Tracey W. R., Nakane M., Pollock J. S., Förstermann U. Nitric oxide synthases in neuronal cells, macrophages and endothelium are NADPH diaphorases, but represent only a fraction of total cellular NADPH diaphorase activity. Biochem Biophys Res Commun. 1993 Sep 15;195(2):1035–1040. doi: 10.1006/bbrc.1993.2148. [DOI] [PubMed] [Google Scholar]
  28. Weiner C. P., Lizasoain I., Baylis S. A., Knowles R. G., Charles I. G., Moncada S. Induction of calcium-dependent nitric oxide synthases by sex hormones. Proc Natl Acad Sci U S A. 1994 May 24;91(11):5212–5216. doi: 10.1073/pnas.91.11.5212. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Xie Q. W., Cho H. J., Calaycay J., Mumford R. A., Swiderek K. M., Lee T. D., Ding A., Troso T., Nathan C. Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science. 1992 Apr 10;256(5054):225–228. doi: 10.1126/science.1373522. [DOI] [PubMed] [Google Scholar]
  30. Yallampalli C., Byam-Smith M., Nelson S. O., Garfield R. E. Steroid hormones modulate the production of nitric oxide and cGMP in the rat uterus. Endocrinology. 1994 Apr;134(4):1971–1974. doi: 10.1210/endo.134.4.8137765. [DOI] [PubMed] [Google Scholar]
  31. Yallampalli C., Garfield R. E., Byam-Smith M. Nitric oxide inhibits uterine contractility during pregnancy but not during delivery. Endocrinology. 1993 Oct;133(4):1899–1902. doi: 10.1210/endo.133.4.8404632. [DOI] [PubMed] [Google Scholar]
  32. Yallampalli C., Izumi H., Byam-Smith M., Garfield R. E. An L-arginine-nitric oxide-cyclic guanosine monophosphate system exists in the uterus and inhibits contractility during pregnancy. Am J Obstet Gynecol. 1994 Jan;170(1 Pt 1):175–185. doi: 10.1016/s0002-9378(94)70405-8. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES